Canada - English - Health Canada

sanofi-aventis canada inc - aflibercept - solution - 100mg - aflibercept 100mg - antineoplastic agents

Canada - English - Health Canada

sanofi-aventis canada inc - aflibercept - solution - 200mg - aflibercept 200mg - antineoplastic agents

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sanofi - aflibercept - solution for infusion - 25mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sanofi - aflibercept - solution for infusion - 25mg/1ml

Singapore - English - HSA (Health Sciences Authority)

sanofi-aventis singapore pte. ltd. - aflibercept - infusion, solution concentrate - 25.0 mg/ml - aflibercept 25.0 mg/ml

European Union - English - EMA (European Medicines Agency)

sanofi winthrop industrie - aflibercept - colorectal neoplasms - antineoplastic agents - treatment of metastatic colorectal cancer (mcrc).

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

bayer plc - aflibercept - solution for injection - 40mg/1ml

Singapore - English - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - ranitidine hcl eqv ranitidine - tablet, film coated - 150 mg - ranitidine hcl eqv ranitidine 150 mg

Singapore - English - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - ranitidine hcl - syrup - 150 mg/10 ml - ranitidine hcl 150 mg/10 ml

Singapore - English - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - ranitidine hcl - injection - 25 mg/ml - ranitidine hcl 25 mg/ml